ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AMYT Amryt Pharma Plc

143.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 143.00 151.00 170.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amryt Pharma Share Discussion Threads

Showing 6676 to 6697 of 7375 messages
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older
DateSubjectAuthorDiscuss
25/6/2021
19:34
Thanks for the reply, richpassi. So I'm still none the wiser on what "meme" stocks are. 🤣🤣
papillon
25/6/2021
18:30
Daily high that is
alphabravo321
25/6/2021
18:30
New high on Nasdaq
alphabravo321
25/6/2021
18:29
Somethings up....
moorsie2
25/6/2021
16:37
What are meme stocks .......I ain't got a clue but been viewing them since a mate who has never bought a share in his life was 'advised' to buy Gamestop @ $2.52 , he was full of how it was going to triple in price ! But the pump and pump of it is excruciating to watch .....100x worse than pvr/logp at its height lol 'too the moon' 'diamond hands' they really do need you and Bones to intervine :)
richpassi
25/6/2021
16:37
Just bought some more AMYT shares seeing they have jumped up on Nasdaq. I sold my AMYT shares after I saw the big price drop on the Nasdaq pre market when the CHMA deal was first announced so it makes sense for me to buy them back for a cheaper price now that they have had a big rise today on Nasdaq.
papillon
25/6/2021
16:15
Amyt up on both AIM and NASDAq, also CHMA up 12%
alphabravo321
25/6/2021
14:51
Yes, richpassi, I continued to follow the AMYT share price on AIM and the ADS's on Nasdaq. Just waiting and biding my time until the Ichimoku chart showed some return to bullishnes,which it has done today. Onwards and upwards (hopefully). Fingers crossed!

The Bitcoin and other cryptos charts turned bearish within the last few months, richpassi. Bitcoin has halved in price from it's May high of 65k. Other cryptos have performed worse. The bubble has finally burst. I reckon Bitcoin could halve again from the current circa 33k price. I was never tempted to buy cryptos. Never really understood them. Same with "meme" stocks. What are "meme" stocks by the way? 🤣.

papillon
25/6/2021
13:49
Welcome back Pap, good to see your still with us, hopefully this is the start of seeing Amyt heading in the right direction, slow and steady , but unfortunately it seems the masses these days are more interested in crypto's and meme stocks :(
richpassi
25/6/2021
13:24
Bought back in today. It looks likely that the AMYT chart is starting to turn bullish.

Hopefully my CVR's will start to bear fruit soon.

papillon
07/6/2021
12:37
By the way, does anyone know if shareholders will get to vote on the Chiasma deal?
whatno
07/6/2021
12:34
These will really fly if they get the priority review voucher - that's a $100million reward for all the hard work.
whatno
07/6/2021
12:32
Yep no adcom required for FDA decision.
bermudashorts
07/6/2021
12:29
No advisory committee required - not really a surprise although still welcome. The drug is not controversial, like say a gene therapy, so FDA obviously feel that they can make the assessmemt without external advice. Fingers crossed for a good result. Things seem to be progressing really well.. I do wonder if they.may even beat the PDUFA date. It has been known to happen...
whatno
04/6/2021
13:32
I got those values from Amryt.

So you have 3 x 30,000 CVRs?

FDA 30,000 x 0.61 = 18,300 (1)
EMA 30,000 x 0.26 = 7,800 (1)
REV 30,000 x 0.61 = 18,300 (2)
------
44,400 USD

1. December 31, 2021, with a sliding scale on a linear basis to zero if before July 1, 2022
2. Oleogel-S10 revenues exceeding US$75,000,000 in any 12-month period prior to June 30, 2024

whatno
04/6/2021
09:00
I asked the question and this is what I got back.

These are based on hitting the target dates. The CVR's diminish in value if the target date is missed until they are eventually nil value.

For each share you owned on Sept 20 2019, you will have received 1 FDA CVR, 1 EMA CVR and 1 Revenue CVR – you should have received hard copy certs from the Registrar for same, or your broker did. The approximate value of each is potentially as follows :



FDA $61 cents
EMA $26 cents
Revenue $61 cents

whatno
03/6/2021
20:35
www.amrytpharma.com/wp-content/uploads/2019/09/Admission-Document-August-2019.pdf

page 78 onwards for full details on the CONTINGENT VALUE RIGHTS

delta0091
03/6/2021
10:12
Excellent news - granting of Priority Review means PDUFA date is comfortably within timescales for CVR deadline.
bermudashorts
03/6/2021
08:41
PDUFA Nov 30.
whatno
03/6/2021
07:52
do read the RNS's. Today confirms the date for the review.
waterloo01
03/6/2021
07:50
I dont think its bad news!
alphabravo321
03/6/2021
07:20
i thought we got this rns a day or 2 days ago already/ whats happening in nov
ali47fish
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older

Your Recent History

Delayed Upgrade Clock